Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 10, 1996, Pages 585-589

  Kishimoto, Yosuke ^a   Shiota, Goshi ^a   Wada, Kouichirou ^a   Kitano, Masayuki ^a   Nakamoto, Kentaro ^a   Kamisaki, Yoshinori ^a   Suou, Takeaki ^a   Itoh, Tadao ^a   Kawasaki, Hironaka ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Chromosome 8p; Hepatocellular carcinoma; Liver cirrhosis; Loss of heterozygosity

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 8P; CLINICAL ARTICLE; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL;

EID: 0029811356     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01221189     Document Type: Article

References (36)

1. Bergerheim USR, Kunimi K, Collins VP, Ekman P (1991) Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosomes Cancer 3:215-220
2. Buetow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet V, Brechot C, Redeker A, Govindarajah S (1989) Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86:8852-8856
3. Ding S-F, Habib NA, Dooley J, Wood C, Bowles L, Delhanty JDA (1991) Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br J Cancer 64:1083-1087
4. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y (1992) Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer and lung cancer. Cancer Res 52:5368-5372
5. Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H, Yagura M, Matsubara K, Nakamura Y (1991) Allelotype study of primary hepatocellular carcinoma. Cancer Res 51:89-93
6. Fujimoto J, Okamoto B, Yamanaka N, Toyosaka A, Mitsunobu M (1991) Flow cytometric DNA analysis of hepatocellular carcinoma. Cancer 67:939-944
7. Fujiwara Y, Ohata H, Kuroki T, Koyama K, Tsuchiya E, Monden M, Nakamura Y (1995) Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene. Oncogene 10:891-896
8. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD, Gazdar AF (1995) Allele-specific specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273:558-563
9. Ishizu H (1989) Flow cytometric analysis of the nuclear DNA content of hepatocellular carcinoma. Jpn J surg 19:662-673
10. Iwao Y, Kim YI, Kaketani K, Nakashima K, Okada K, Kobayashi M (1993) Stemline heterogeneity of nuclear DNA in hepatocellular carcinoma. Hepatogastroenterology 40:491-495
11. Kerangueven F, Essioux L, Dib A, Noguchi T, Allione F, Geneix J, Longy M, Lidereau R, Eisinger F, Pébusque M-J, Jacquemier J, Bonäti-Pellié C, Sobol H, Birnbaum D (1995) Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene 10:1023-1026
12. Kishimoto Y, Sugio K, Hung JY, Virmani AK, McIntire DD, Minna JD, Gazdar AF (1995) Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J Natl Cancer Inst 87:1224-1229
13. Knowles MA, Shaw ME, Proctor AJ (1993) Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction length polymorphisms and microsatellite polymorphisms. Oncogene 8:1357-1364
14. n dinucleotide repeat polymorphisms. Am J Med Genet 52:79-84
15. Livni N, Eid A, Ilan Y, Rivkind A, Rosenmann E, Blendis LM, Shouval D, Galun E (1995) p53 expression in patients with cirrhosis with and without hepatocellular carcinoma. Cancer 75:2420-2426
16. Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, Pietruk T, Powell IJ (1995) Evidence for three tumor suppressor gene on chromosome 8p in human prostate cancer. Cancer Res 55:5390-5395
17. Marshall CJ (1991) Tumor suppressor genes. Cell 64:313-326
18. McEntee GP, Batt KA, Kazmann JA, Ilstrup DM, Nagorney DM (1992) Relationship of nuclear DNA comtent to clinical and pathologic findings in patients with primary hepatic malignancy. Surgery 111:376-379
19. Miki Y, Nishisho I, Miyoshi Y, Utsunomiya J, Nakamura Y (1992) Interstitial loss of the same region of 5q in multiple adenomas and a carcinoma derived from an adenomatous polyposis coli (APC) patient. Genes Chromosomes Cancer 4:81-83
20. Murakami Y, Hayashi K, Hirohashi S, Sekiya T (1991) Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51:5520-5525
21. Nagasue N, Kohno H, Hayashi T, Yamanoi A, Uchida M, Takemoto Y (1993) Lack of intratumoral heterogeneity in DNA ploidy pattern of hepatocellular carcinoma. Gastroenterology 105:1449-1454
22. Nishida N, Fukuda Y, Kokuryu H, Sadamoto T, Isowa G, Honda K, Yamaoka Y, Ikenaga M, Imura H, Ishizaki K (1992) Accumulation of allele loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer 52:862-868
23. O'Connell P, Pekkel V, Fuqua S, Osborne CK, Allred DC (1994) Molecular genetic studies of early breast cancer evolution. Breast Cancer Res Treat 32:5-12
24. Okada S, Ishii H, Nose H, Okusaka T, Kyogoku A, Yoshimori M, Sakamoto M, Hirohashi S (1995) Intratumoral DNA heterogeneity of small hepatocellular carcinoma. Cancer 75:444-450
25. Pääbo S (1989) Ancient DNA: extraction, characterization, molecular cloning, and enzymatic amplification. Proc Natl Acad Sci USA 86:1939-1943
26. Sakamoto M, Hirohashi S, Shimosato Y (1991) Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22:172-178
27. Simon D, Knowles BB, Weith A (1991) Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 6:765-770
28. Sugio K, Kishimoto Y, Virmani AK, Hung JY, Gazdar AF (1994) K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res 54:5811-5815
29. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM, Rabbitts P (1992) p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7:1989-1997
30. Takahashi K, Kudo J, Ishibashi H, Hirata Y, Niho Y (1993) Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology 17:794-799
31. Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R, Sugimachi K (1993) Tumor progression in hepetocellular carcinoma may be mediated by p53 mutation. Cancer Res 53:2884-2887
32. Tsuda H, Zhang W, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T, Hirohashi S (1990) Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6791-6794
33. Walker GJ, Hayward NK, Falvey S, Cooksley WGE (1991) Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res 51:4367-4370
34. Wang HP, Rogler CE (1988) Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet 48:72-78
35. Wistuba H, Sugio K, Hung JY, Kishimoto Y, Virmani AK, Roa I, Albores-Saavedra J, Gazdar AF (1995) Allele-spacific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 55:2511-2515
36. Zhang W, Hirohashi S, Tsuda H, Shimosato Y, Yokota J, Terada M, Sugimura T (1990) Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res 81:108-111